Patents by Inventor Jian Ni

Jian Ni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Text classification using models with complementary granularity and accuracy
    Patent number: 11373041
    Abstract: A processor may receive a text segment. The processor may analyze the text segment at a plurality of granularity levels wherein each of the plurality of granularity levels has a comparative selection value for identifying one or more objects of interest within the text segment. The processor may select an optimized granularity level with an optimum comparative selection value. The processor may identify the one or more objects of interest within the text segment. The processor may display the one or more objects of interest to a user.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: June 28, 2022
    Assignee: International Business Machines Corporation
    Inventors: Jian Ni, Radu Florian, Salim Roukos, Vittorio Castelli
  • Anti-PD-1 antibodies and uses thereof
    Patent number: 11352429
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: May 19, 2021
    Date of Patent: June 7, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Anti-TNFRSF9 antibodies and uses thereof
    Patent number: 11292849
    Abstract: This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: April 5, 2022
    Assignee: Eucure (Beijing) Biopharma Co., Ltd.
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • TEXT CLASSIFICATION USING MODELS WITH COMPLEMENTARY GRANULARITY AND ACCURACY
    Publication number: 20220092262
    Abstract: A processor may receive a text segment. The processor may analyze the text segment at a plurality of granularity levels wherein each of the plurality of granularity levels has a comparative selection value for identifying one or more objects of interest within the text segment. The processor may select an optimized granularity level with an optimum comparative selection value. The processor may identify the one or more objects of interest within the text segment. The processor may display the one or more objects of interest to a user.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 24, 2022
    Inventors: Jian Ni, Radu Florian, Salim Roukos, Vittorio Castelli
  • ANTI-PD-L1 ANTIBODY AND USE THEREOF
    Publication number: 20220073621
    Abstract: The present application provides an anti-PD-L1 antibody, an antigen-binding fragment thereof, and use thereof. The present application also provides a multispecific antibody such as a bispecific antibody, a conjugate, and a composition comprising the anti-PD-L1 antibody or the antigen-binding fragment thereof, and use thereof in treatment of diseases such as cancer.
    Type: Application
    Filed: August 20, 2020
    Publication date: March 10, 2022
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Ya'nan Guo, Yunyun Chen
  • Genetically modified non-human animal with human or chimeric TIM-3
    Patent number: 11240995
    Abstract: The present disclosure relates to the genetically modified non-human animals that express a human or chimeric (e.g., humanized) T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and methods of use thereof.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: February 8, 2022
    Assignee: Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
    Inventors: Yuelei Shen, Jian Ni, Yanan Guo, Rui Huang, Meiling Zhang, Lei Zhao, Yang Bai
  • ANTI-PD-1 ANTIBODIES AND USES THEREOF
    Publication number: 20210403570
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: September 17, 2021
    Publication date: December 30, 2021
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • ANTI-CD40 ANTIBODIES AND USES THEREOF
    Publication number: 20210403588
    Abstract: This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: September 8, 2021
    Publication date: December 30, 2021
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Anti-PD-1 antibodies and uses thereof
    Patent number: 11155625
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: October 26, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • Anti-CD40 antibodies and uses thereof
    Patent number: 11142582
    Abstract: This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: October 12, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • ANTI-PD-1 ANTIBODIES AND USES THEREOF
    Publication number: 20210284735
    Abstract: This disclosure relates to anti-PD-1 (Programmed Cell Death Protein 1) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: May 19, 2021
    Publication date: September 16, 2021
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • ANTI-CD3e ANTIBODIES AND USES THEREOF
    Publication number: 20210269525
    Abstract: This disclosure relates to anti-CD3e (T-cell surface glycoprotein CD3 epsilon chain) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: June 19, 2019
    Publication date: September 2, 2021
    Inventors: Yi Yang, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni, Yanan Guo
  • Real-time speech analysis method and system using speech recognition and comparison with standard pronunciation
    Patent number: 11062726
    Abstract: A method of providing real-time speech analysis to a user includes capturing a speech input, performing a real-time recognition of the speech input including converting the speech input to a text, analyzing the recognized speech input to identify an error in a voice of the user, the analyzing including comparing a voice of a correct text generated by an automated speech generation system with the captured speed input, and processing the text to extract a context dialog prompt.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: July 13, 2021
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Sasha P. Caskey, Jian Ni, Andrzej Sakrajda, Hui Wan, Cheng Wu
  • ANTI-OX40 ANTIBODIES AND USES THEREOF
    Publication number: 20210206866
    Abstract: This disclosure relates to anti-OX40 (TNF Receptor Superfamily Member 4, or TNFRSF4) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: January 5, 2021
    Publication date: July 8, 2021
    Inventors: Yi Yang, Yanan Guo, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Xiaodong Cheng, Yuelei Shen, Jian Ni
  • ANTI-TNFRSF9 ANTIBODIES AND USES THEREOF
    Publication number: 20210206867
    Abstract: This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: March 12, 2021
    Publication date: July 8, 2021
    Inventors: Yi Yang, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen
  • ANTI-CTLA4 ANTIBODIES AND USES THEREOF
    Publication number: 20210188981
    Abstract: This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: February 22, 2021
    Publication date: June 24, 2021
    Inventors: Yi Yang, Yanan Guo, Xiaodong Cheng, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni
  • Anti-CTLA4 antibodies and uses thereof
    Patent number: 11034764
    Abstract: This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: June 15, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Yanan Guo, Xiaodong Cheng, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni
  • ANTI-CD40 ANTIBODIES AND USES THEREOF
    Publication number: 20210155705
    Abstract: This disclosure relates to anti-CD40 (TNF Receptor Superfamily Member 5) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Application
    Filed: January 14, 2021
    Publication date: May 27, 2021
    Inventors: Yi Yang, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni, Yanan Guo, Yunyun Chen, Jingshu Xie
  • Anti-CTLA4 antibodies and uses thereof
    Patent number: 11001632
    Abstract: This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 11, 2021
    Assignee: Eucure (Beijing) Biopharma Co., Ltd
    Inventors: Yi Yang, Yanan Guo, Xiaodong Cheng, Yunyun Chen, Jingshu Xie, Chunyan Dong, Fang Yang, Chengyuan Lu, Yuelei Shen, Jian Ni
  • GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC CD47
    Publication number: 20210120790
    Abstract: The present disclosure relates to genetically modified non-human animals that express a human or chimeric (e.g., humanized) CD47, and methods of use thereof.
    Type: Application
    Filed: November 2, 2020
    Publication date: April 29, 2021
    Inventors: Yuelei Shen, Yang Bai, Jian Ni, Rui Huang, Chengzhang Shang, Yanan Guo